Bayer Fails to Block Generic Cancer Drug in Supreme Court

German drug maker Bayer has failed in a last-ditch attempt to block the sale of a cheap generic version of its cancer drug Nexavar in India, after the Supreme Court ruled against it on Friday. The decision, which upholds earlier rulings, will be seen as a blow for global drug makers' efforts to hold on to exclusivity on high-price medicines in India. Indian generics group Natco Pharma said the court had dismissed Bayer's chal...